Curiox Biosystems

Curiox Biosystems

Biotechnology Research

Transforming the landscape of cell sample preparation and bringing personalized automation to every scientist

About us

Curiox Biosystems is committed to enabling accurate biological analysis through automation. Next-generation methods and applications--including single-cell 'omics technologies, flow cytometry, immunotherapy, and cell and gene therapy--deserve a next-generation approach to preparing samples for analysis. That’s why Curiox invented Laminar Wash technology, the only sample preparation method that eliminates centrifugation and the problems it introduces. The methodology keeps cells in their native state, improves cell retention and viability, and enhances reproducibility and miniaturization, ultimately leading to reduced costs and workflow standardization.

Industry
Biotechnology Research
Company size
51-200 employees
Headquarters
Singapore
Type
Privately Held
Founded
2008
Specialties
Cell-based assays, Wash-based suspension cell assays, Primary cell screens, Assay miniaturization, centrifuge, immunology, Covid, Biosafety, sample preparation, automation, antibody discovery, cell therapy, immunoassays, flow cytometry, mass cytometry, single cell, proteogenomics, SEQ, cytof, fluidigm, 10x genomics, phenotyping, oncology, clinical, and Research and development

Locations

Employees at Curiox Biosystems

Updates

Similar pages

Funding